Aptose Biosciences completed acquisition by Hanmi Pharmaceutical for C$2.41 per share
Aptose Biosciences consummated a plan of arrangement on June 30, 2026, under which HS North America Ltd., a wholly owned subsidiary of Hanmi Pharmaceutical…
$2.41cash$3.5M2.0Mshares